Finding responsibility and a road to recovery as US opioid deaths demand swift action

13 March 2017

Physicians, pharma or regulators – who has caused the US opioid crisis? And how can they solve it?

Of course, all three have contributed to a problem that is as stark when viewed in statistical terms as it is on hearing so many of the heartbreaking stories of overdose deaths and of lives being ruined by addictions that often stemmed from well-intended medical interventions.

According to the American Society of Addiction Medicine, drug overdose is the leading cause of accidental death in the USA, having caused 52,404 such deaths in 2015.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK